No Data
No Data
TIGERMED (03347) provides guarantees for Other holding subsidiaries.
TIGERMED (03347) issued an announcement that the company's controlling subsidiary HeYa Medical Technology (Shanghai) Co., Ltd. (hereinafter referred to as...)
Express News | The USA Biological Security Act was not included in the CR bill.
Express News | Ping An Securities Pharmaceutical Industry 2025 Annual Strategy Report: Exploring new growth from payment sources, focusing on innovation, going overseas, equipment upgrades, and Consumer recovery.
Express News | CITIC Construction Investment: Optimistic about investment opportunities in the pharmaceutical industry in 2025, focusing on new volume and industry integration opportunities
Express News | The tenth batch of national centralized procurement will open bids in Shanghai tomorrow: involving 62 varieties, with strict measures to prevent companies from colluding and manipulating the bidding.
Express News | Shanghai aims to nurture around 10 internationally competitive listed companies in key industries such as integrated circuits, biomedical, and new materials by 2027, forming a merger and acquisition trade scale of 300 billion yuan.
No Data